TY - JOUR TI - Pharmaceutical Industry’s R&D in Developing Countries Case Study: India JO - Roshd -e- Fanavari JA - Iranian Academic Center for Education,Culture and Research LA - fa SN - 1735-5486 AU - سیده صدیقه جلال پور AU - فرانک نادی AD - آزاد اسلامی واحد علوم تحقیقات AD - آزاد اسلامی واحد علوم تحقیقات Y1 - 2015 PY - 2015 VL _ 42 IS - 1 SP - 1 EP - 10 KW - Research and Development (R&D) KW - Pharmaceutical Industry KW - Developing Countries KW - Bio Technology. DO - 10.7508/jstpi.2015.02.005 N2 - Research and Development plays a key role in creating knowledge and technology, hence planning and investment in this area is too important for countries to keep their permanency of competitive advantages. For the time beingdeveloping countries from one side, aretypicallyimportinghigh technologyfromdeveloped countries, and from the other sidein recent years supply of domestic healthcareneeds faced with new barriers such as high costof drugs and the emergence of new international. Consequently the situation leads to formation and enabling of domestic R&D in Pharmaceutical industry. this paper have considered the situation of Pharmaceutical industry’s R&D in developing countries and then examined the related theories, Having in mind the India’s achievements in Pharmaceutical industry through adoption and implementation of appropriate R&D policies,. India's experiences in Pharmaceutical industry especially in bio technology looked over and finally the pass through manner of India from 1947 till now is presented in a suitable framework. The framework’s features consist of types of R&D, forms of innovation (product or process) and the time with in each period. It may used as guidance for R&D activities in Pharmaceutical industry in other developing countries. UR - http://rimag.ir/fa/Article/20013 L1 - http://rimag.ir/fa/Article/Download/20013 TY -JOURId - 20013